Align Technology, Inc.
Align Technology manufactures and sells Invisalign clear aligners and iTero intraoral scanners, with its dominant political signal being $17.0M in annual doctor payments (get_political_influence.doctor_payments) and a single executive branch holding by Donald J. Trump (get_executive_branch_exposure.by_ticker[0].holdings[0]).
BusinessWhat ALGN does
The company operates in the medical device sector, generating revenue primarily from the sale of its Invisalign clear aligner systems and iTero intraoral scanners and services to orthodontists and dentists. Its business model is B2B2C, relying on dental professionals to prescribe and manage treatment, supported by significant direct payments to doctors for services like training and education.
12 months past · 3 months futureALGN activity timeline
Executive Branch ConflictsALGN held by Trump-administration officials
Lifetime Government AwardsALGN federal contracts by year
Smart Money · 13F HoldingsHedge funds holding ALGN
Politicians Trading ALGNMembers of Congress with recent ALGN positions
Congressional TradesWho in Congress is trading ALGN
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
No Form 4 activity recorded in the last 180 days.
Bills Affecting ALGNLive legislation impacting this stock
Political ProfileWhere ALGN sits in Washington
[object Object]
STRUCTURAL: High regulatory density (85) from healthcare sector bills and doctor payment exposure ($17.1M annually). EVIDENTIARY: No corporate insider buys in 180 days (get_corporate_insider_signal.total_buys: 0), no federal contracts, and congressional trading is limited to two members executing small sales (Top congressional traders array). Net: Structural regulatory risk is not offset by bullish evidentiary signals from insiders or government spending.
Regulatory ExposureThreats & opportunities
Regulatory threats
-
Heightened scrutiny of manufacturer payments to healthcare providers under anti-kickback statutes.HHS-OIG / DOJ"get_political_influence.doctor_payments shows $17.1M in 2023 payments to doctors, a recurring compliance exposure."
Regulatory opportunities
-
Potential for expanded insurance coverage or favorable reimbursement codes for clear aligner therapy.CMS"Eight recent healthcare sector bills show measurable revenue impact (bill_impacts array), indicating legislative activity in its core market."
Live signals + predictions for ALGN — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades ALGN
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord